New Code Cracks Down on Pharma Gifts, Travel Perks for Healthcare Professionals

The Department of Pharmaceuticals in India has notified a new code, known as the Uniform Code for Pharmaceuticals Marketing Practices (UCPMP) 2024, which aims to regulate the marketing practices of pharmaceutical companies and their interactions with healthcare professionals.

Representative image

Key Provisions of the UCPMP 2024

The UCPMP 2024 introduces several key provisions to ensure ethical and transparent practices in the pharmaceutical industry:

• Prohibition on Gifts and Travel Facilities: Pharmaceutical companies and their agents are prohibited from offering gifts, travel facilities, or any other pecuniary advantage to healthcare professionals or their family members.
• Restrictions on Free Samples: The supply of free samples of drugs is prohibited to individuals who are not qualified to prescribe such products.
• Ethical Committees and UCPMP Portals: Pharmaceutical associations are required to establish Ethics Committees for Pharmaceutical Marketing Practices (ECPMP) and set up dedicated UCPMP portals on their websites to facilitate the implementation of the code.
• Accurate and Verifiable Drug Information: The promotion of drugs must be consistent with the terms of their marketing approval, and information about drugs must be balanced, up-to-date, verifiable, and capable of substantiation.
• Ethical Conduct of Medical Representatives: Medical representatives must maintain a high standard of ethical conduct, comply with the code's requirements, and refrain from using inducements or subterfuge to gain access to healthcare professionals.

Promoting Ethical Practices in the Pharmaceutical Industry

The UCPMP 2024 aims to promote ethical practices in the pharmaceutical industry and ensure that healthcare professionals are not influenced by financial incentives or other inducements when making decisions about prescribing drugs. By regulating the marketing practices of pharmaceutical companies, the code seeks to protect the integrity of the healthcare system and safeguard the interests of patients.

The implementation of the UCPMP 2024 is a significant step towards ensuring transparency and ethical conduct in the pharmaceutical industry in India. By prohibiting gifts, travel facilities, and other inducements, the code aims to create a level playing field for pharmaceutical companies and foster a culture of responsible marketing practices. This will ultimately benefit healthcare professionals, patients, and the pharmaceutical industry as a whole.